DatasetName,RCSD1_S(105) RCSD1_S(108) RCSD1_S(11) RCSD1_S(123) RCSD1_S(126) RCSD1_S(127) RCSD1_S(149) RCSD1_S(176) RCSD1_S(18) RCSD1_S(19) RCSD1_S(2) RCSD1_S(212) RCSD1_S(219) RCSD1_S(220) RCSD1_S(242) RCSD1_S(267) RCSD1_S(268) RCSD1_S(284) RCSD1_S(3) RCSD1_S(321) RCSD1_S(4) RCSD1_S(5) RCSD1_S(6) RCSD1_S(68) RCSD1_S(73) RCSD1_S(75) RCSD1_S(78) RCSD1_S(83) RCSD1_S(86) RCSD1_S(90) RCSD1_S(93) RCSD1_T(124) RCSD1_T(336) RCSD1_T(348) RCSD1_T(94),RCSD1_S(116) RCSD1_S(120) RCSD1_S(147) RCSD1_S(15) RCSD1_S(177) RCSD1_S(179) RCSD1_S(186) RCSD1_S(216) RCSD1_S(237) RCSD1_S(238) RCSD1_S(244) RCSD1_S(254) RCSD1_S(288) RCSD1_S(298) RCSD1_S(333) RCSD1_S(346) RCSD1_S(351) RCSD1_S(52) RCSD1_S(53) RCSD1_S(79) RCSD1_S(8) RCSD1_S(82) RCSD1_T(1) RCSD1_T(287),RCSD1_S(13) RCSD1_S(164) RCSD1_S(17)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,0.4971246268499519,0.6100736789879331,
FSO2013_Ratio M/L normalized Rep3,,,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,0.47503784448482694,0.5942711053852732,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,,,
HS2024_6_B_T3,0.5047565092401233,0.6077987108724949,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,,,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,0.508613747483581,0.6517653145245063,0.28409959381276745
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,0.5079009488712469,0.6233376008773382,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,0.47783006220784063,0.598971197665595,
FSO2013_Ratio M/L normalized Rep1___1,,,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,0.4851468558189138,,
RB2022_5_PreEndurance,0.48405308416903725,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,,,
WZ2023_Pu_010_30min,,,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,0.48805761461099256,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,,,
RB2022_8_RecoveryEndurance,0.48006940946924603,0.6129933492797786,
KBE2022_Log2_Ex_14_U,0.49232478215270775,0.6483149795969917,0.2776917496553337
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,,,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,,
RB2022_5_PreSprint,0.47669532043545154,,
PG2020_Intensity 8h_C,,,
AH2018_SILAC_MR_2_N,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,0.6153320964640656,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,,0.6228119616051775,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),0.4896098109711067,,
UK2020_HCM_2,0.49569288323955313,0.6211700909271902,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,,,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,0.4952304308379235,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,0.5969964124557455,
GF2025_P6_Sph,,,
RB2022_2_PreSprint,0.49189672626177816,0.5996594039115709,
ZX2022_CB treated Replicate 3,,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,0.5081159152100295,0.623721399366907,
KBE2022_Log2_Ex_34_U,0.5112113215012627,0.6502853503704203,0.2929459896162019
WZ2023_Pu_005_10min,,,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.49536136083778864,0.6363718655876086,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,,,
AH2018_SILAC_MR_2_X,,,
HS2024_4_PD_T2,0.4893270719857318,0.6002933360237991,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,0.4976404775660924,0.6046693922718246,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,0.43493294409887323,0.5809520865142636,
FR2021_Norm.Intensity.B,0.4901497641042259,0.6045310920365771,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,0.4924247376310484,,
EJN2021_3_Rest_Basal,0.49736648650577,0.626077289108817,
CR2017_Ratio Replicate 1.3,0.48114585089885165,0.6211982004534607,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,,,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,,
HS2024_7_PD_T2,0.5001218830052843,0.6232951252192968,
FSO2013_Ratio H/L normalized Rep1___1,,,
AH2018_LFQ_1_C,,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,0.4951942425683617,0.6445982019803854,
HS2024_3_B_N1,0.4755971227102211,0.5945200842172642,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,,,
CK2022_11 40-1,0.49599828309896227,0.6366911585466716,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,,
FSO2013_Ratio H/L normalized Rep2,,,
WZ2023_Pu_005_20min,,,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,0.4376114229846691,0.5802061600830662,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,0.4892107762451627,0.6138300413312318,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,0.47902325904629495,0.6043095763842251,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,0.5340548474999235,0.6081171938773532,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,0.49088519587350044,0.5990724889052625,
RB2022_2_PreStrength,0.49071090303205817,0.6166191186720389,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,0.5064359953337417,0.6268318752813057,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,0.47710760443931455,0.5927701915999445,
CK2022_1 200-1,0.47968516315327037,0.6160259699020355,
PG2020_Intensity Mock_10h_D,,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,0.49653427137434514,0.6172149495828242,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,0.4799712668993181,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,,,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.5008465802199171,0.6393099359610636,
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,,,
KBE2022_Log2_Ex_8_T,0.5045454265728966,0.6559039643924293,0.22103006469933947
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,0.49294401926279974,0.6272217336458695,
RN2012_L11,0.489164432059519,0.6227079479796669,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,0.5187839291991779,0.6533370016924885,
AH2018_LFQ_M_2_C,,,
CK2022_3 40-1,0.4729050325656911,0.60953171681399,
RBK2021_1260T Early,0.4906778648505984,0.6245613638591399,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,0.49571847583075257,0.607409634276538,
YA2020_Reporter_intensity_Cancer_No.5,,,
HH2022_Reporter intensity 8,0.48802336271720476,0.6192093090556524,
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,,,
EJN2021_5_Rest_Basal,0.5030990112153668,0.6237499437878625,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,0.4901947102502758,0.6071177094338284,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,,
YA2020_Reporter_intensity_Normal_No.1,,,
HS2024_3_B_T1,0.5156371787915819,0.6168484640331421,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,0.4939671677811262,,
RB2022_1_PostEndurance,0.49157329121768734,,
CR2017_Ratio Replicate 3,0.5029040943785337,0.6169170980067123,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,0.4919650622107294,0.6154272382597777,
RB2022_3_PostSprint,0.48574113660309776,0.5889181247603829,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,,,
HS2024_8_I_T3,0.4678280044973921,0.6044694488082306,
CF2017_EOC 3,0.49316688012612664,0.619599918493419,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,0.4716758568206101,0.6119260647543562,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,,,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.4702526788883156,0.6089488514750272,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,0.6220828094379481,
CK2022_8 16-1,0.47760085564823324,0.5931479149400425,
KS2014_Intensity N3,,,
RB2022_4_RecoveryEndurance,0.4895204645938706,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,,
FSO2013_Ratio H/M normalized Rep2,,,
RAM2015_Log2 A,,,
HS2024_8_PD_T1,0.4845068802812786,0.6176728309549879,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,0.49437058185696836,0.6276089952963669,
KS2014_Intensity E15_2,,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,
HS2024_7_I_T1,0.489462398718073,0.6131382840950697,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,0.48729634921310927,0.5976979060518742,
AH2018_SILAC_M_3_X,,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,0.5017680004729909,0.6537430327185864,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,0.4984901779926526,0.5965136796483265,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,0.5074828629612478,0.6230870806636758,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,,,
HS2024_6_B_N1,0.46218442195510323,0.6056074519831515,
KBE2022_Log2_Ex_27_T,0.4964100342558411,0.6491619245888723,0.27967262823797506
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.4875351601166507,0.619471372405091,0.2852789113132745
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,0.48920133036887176,0.6300009320924629,
AH2018_SILAC_IT_3_X,,,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,
FSO2013_Ratio M/L normalized Rep2,,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,0.49291124535918707,0.6228829852169987,
SR2019_HCC1954_Biol_repl_2,,,
CK2022_14 40-1,0.4790110737339147,0.6250407027860578,
RB2022_6_PreSprint,0.492695955409432,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,,
DL2023_control-1,,,
AR2021_ALG 10 μM,,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,,,
EJN2021_4_Rest_Ins,0.4774140338865977,0.6080845027368802,
RN2012_H05,0.49188919811947623,0.619757937819979,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,0.49020015858057764,,
EJN2021_1_Rest_Ins,0.4885765398074172,0.621997911507111,
HH2022_Reporter intensity 3,0.48834359126915045,0.6175527555505039,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,,,
JW2021_After_3,,,
GF2025_P8_Sph,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,,
CK2022_11 200-1,0.4997490439647203,0.6447286120721821,
CK2022_12 200-1,0.4934780816394603,0.6472099104926917,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,0.5038385372115423,0.6265981124949043,
WZ2023_Su_010_20min,,,
AH2018_TMTMS2_2_N,,,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,0.5080146025784482,0.6481715133051491,0.2989924726815258
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.4942283686305845,0.621412123413283,0.2624685918408866
AH2018_TMTMS3_Pool,,,
KS2014_Intensity N4,,,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,0.4882023777339017,0.6105373259280693,
CK2022_14 200-1,0.48422666446550927,0.6360069546950081,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,0.48919186819141114,0.6095006416334966,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,,,
AST2020_anti-CD3+PDL2.2,0.508578316454587,0.6239840846109747,
PG2020_Intensity Mock_10h_A,,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,0.48548987062407106,0.6209369487854247,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,0.48364521730483767,0.6154397802298636,
GF2025_P1_Adh,,,
GF2025_P1_Sph,,,
EJN2021_5_Ex_Basal,0.5018019075629848,0.6255888275900999,
HS2024_7_I_T3,0.47727530312737565,0.6171414958322617,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,,,
CF2017_EOC 1,,,
CK2022_3 200-1,0.48009261982286955,0.6156589037854371,
AH2018_LFQ_IT_3_C,,,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.4921951244842323,,
RB2022_3_RecoverySprint,0.5083278155928538,0.6410784299532436,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,0.47340196568884463,0.5941531462671651,
HS2024_5_B_T1,0.48028588506653347,0.5927220376855514,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,0.4836658260364741,0.5967005052717328,
RB2022_6_PreStrength,0.4863301560981107,,
CK2022_2 40-1,0.4702645796294459,0.6086286263318123,
RB2022_1_PostSprint,,,
CK2022_4 200-1,0.47932965415964635,0.616091485699772,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,0.47381095198974027,0.5940358169368322,
AR2021_ALG 1 μM,,,
HS2024_4_B_T1,0.491435056166162,0.6130731074175847,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,0.5010343497530972,0.6205816675896682,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,0.5142185322253721,0.6259272814553724,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,,,
CK2022_9 16-1,0.49794423021519124,0.6272779706116899,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.4848381760574671,0.6353737520972378,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,,
CK2022_16 16-1,0.48004308654857925,0.6144451089383208,
FS2019_db/db3,,,
CK2022_15 40-1,0.47750472859024234,0.6254695020698895,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,0.5056032320976476,0.6472313899236527,0.2989798031567205
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,,,
HS2024_5_PD_T3,0.5073856988669819,0.6194903539033714,
AH2018_TMTMS3_3_X,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,0.5048174568452791,0.6524006372292995,0.2175885097881559
AH2018_LFQ_M_1_N,,,
KBE2022_Log2_Ex_27_U,0.49607815694321067,0.6463756798398339,0.29207993871185245
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,0.4869453916230973,0.6386393754763546,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,0.49123741974813007,0.5987784266420273,
YA2020_Reporter_intensity_Normal_No.4,,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,0.49278612555669454,0.6289993384661817,
RN2012_L13,0.4927888048692208,0.6138899276622162,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,0.49818309574944114,0.6622599802026167,0.3231117033507373
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,0.5009372906263284,0.6142395867457618,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,0.4827134966407852,0.6152101919374723,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.49552264731335416,0.6352685518375913,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,,0.6122655054241523,
HH2022_Reporter intensity 6,0.4968274144581452,0.6223724254531097,
RB2022_2_RecoveryStrength,0.4816048924369383,0.6280171238612454,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,0.6192323379112527,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,,,
GF2025_P3_Adh,,,
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,,,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,,0.6268018232980732,
KBE2022_Log2_Ex_19_U,0.497521901451099,0.6444842493433448,0.2556850843608022
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,0.48677317453699315,0.6246865328791803,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,0.4907507573870185,,
AST2020_Control,0.506765872226961,0.6225840477921163,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),0.4915497858421321,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,,,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,0.49988505489417046,0.6155584085596512,
RB2022_7_RecoverySprint,0.49422268692511784,0.6131591279080124,
YA2020_Reporter_intensity_Normal_No.3,0.4886402963507764,,
HS2024_8_B_T2,0.47024244738561694,0.6154854477887403,
AH2018_LFQ_1_X,,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,0.4888505481303745,0.592828417264176,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,,
HH2022_Reporter intensity 1,0.48802842065538093,0.6176249968616544,
HH2022_Reporter intensity 2,0.4880001519991415,0.6172943761986713,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,0.47219762894886097,0.5656186969298224,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,0.6160105476877749,
EP2017_Untreated R#2 log2 ratio,,,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,0.4897371615178693,0.6482466351522597,
CR2017_Ratio Replicate 2,0.5158459939574117,0.5951379447974557,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,,,
AR2021_KD 72h,,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,0.4973874848627845,0.6598978242931453,0.3502317383613885
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,,,
KBE2022_Log2_Ex_9_U,0.4989708424268605,0.65297070636196,0.2526027705096414
AH2018_SILAC_M_3_N,,,
KBE2022_Log2_Ex_13_T,0.5001003788853016,0.6517048423460943,0.2246772472759099
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,,,
CF2017_OSE 29,0.4907700269329552,0.6194343673274937,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,0.49197920754793945,0.614190828632131,
PG2020_Intensity 10h_A,,,
RN2012_L12,0.4914676345971998,0.6195069634236433,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,0.4910804917495275,0.6042569428715555,
FSO2013_Ratio H/M normalized Rep1___1,,,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.4896872854224939,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.4750290683380815,0.6116009832728699,
RB2022_7_RecoveryEndurance,0.4923554839295449,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,0.49291262779428585,0.6273912030885905,
TM2022_S2.12h.B,,,
RN2012_L15,,0.6087600600185158,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,0.5060723898385935,0.6505242061244914,0.29239960958375927
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,,
RB2022_1_PreSprint,0.4901164566127976,,
HS2024_4_I_N1,0.4973701081489943,0.5922311210040564,
CK2022_7 200-1,0.4818156077846303,0.6206187041276376,
CK2022_5 200-1,0.480537470433254,0.6195337945204297,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,,,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,0.49500419582749605,,
AH2018_LFQ_2_C,,,
AH2018_SILAC_MR_1_X,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,0.5038520609273204,0.6425518224327282,0.29072954118880406
AH2018_SILAC_3_C,,,
EJN2021_5_Rest_Ins,0.48662240102419585,0.6163711471664305,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,0.6289978373350268,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,,,
CK2022_4 16-1,0.4786345144617868,0.5950226018735402,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,0.5028437474748975,0.6279941857746375,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,
FSO2013_Ratio H/L normalized Rep3,,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,0.46397387634380416,0.5958039681604917,
KBE2022_Log2_Ex_9_T,0.5009844913462893,0.6561924011958183,0.25392326386787817
AH2018_SILAC_IT_2_N,,,
AH2018_SILAC_IT_1_X,,,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,0.4816239931709796,0.6298541065703597,
UK2020_UA_2,0.4949019377135644,0.6199924630939234,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,,,
WZ2023_Pe_025_20min,,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,,,
HS2024_4_I_N2,0.5280704084506207,0.6197416513791764,
AH2018_TMTMS2_3_N,,,
RN2012_H06,,0.6281355620504453,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,0.48286603100092496,0.6133922952322507,
WZ2023_Su_005_30min,,,
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,0.49594599635178693,0.617788047876357,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.4824238869572378,0.6218103485228994,
WZ2023_Su_025_10min,,,
AH2018_LFQ_IT_4_X,,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,0.5009715635078136,0.6203657087048812,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,0.4853663775762913,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,,,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,0.495076967892776,,
KS2014_Intensity,,,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,
LY2019_P7+,,0.620655495214538,
EP2017_Untreated R#1 normalized log2 ratio,,,
RN2012_L10,0.4894032300355437,0.6140854382219686,
PG2020_Intensity 4h_C,,,
EP2017_Mitotic R#3 normalized log2 ratio,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,0.5071317813875131,0.6523854669029056,0.2895253827335049
RB2022_8_PostStrength,0.49061945141732144,0.5994986423764264,
AH2018_SILAC_IT_2_X,,,
HS2024_4_B_T3,0.49570402588071344,0.610474384443266,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,0.49338951363695255,0.6237611452590442,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,0.48624776045688584,0.6162760643336332,
KBE2022_Log2_Ex_6_U,0.49996536341919856,0.651218777623607,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.5088783099827134,0.5952156868996533,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.48233882655618876,0.6357208155943423,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,,,
GF2025_P9_Sph,,,
CK2022_6 200-1,0.48073012735216514,0.6196267271747581,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,0.4962561165830678,0.6196316267460773,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,0.498139947436833,0.6137349522266755,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,0.48309891647758424,0.6055782510733895,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,,,
EP2017_Untreated R#3 normalized log2 ratio,,,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.481683852434558,0.6212338002161928,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,0.4725256071520587,0.583598284387509,
RB2022_7_PostEndurance,0.4958706010412644,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,0.48980617946494537,0.6014745714152805,
KBE2022_Log2_Ex_29_T,0.5059378253315768,0.6602391066441702,0.25588992343691946
HS2024_7_I_T2,0.4785631335082748,0.6147857816255483,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,0.4973776702992191,0.6002318916568935,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,0.49387498944735625,0.6264410470659317,
FR2021_Intensity.M,0.4888505481303745,0.592828417264176,
RB2022_2_PostSprint,0.49530118140623447,,
AH2018_SILAC_MR_3_N,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,0.49302958500818317,0.6221480889102061,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,0.49228074959277673,0.6455293159322664,
EP2017_Untreated R#3 log2 ratio,,,
RB2022_2_PostStrength,0.49273945979185185,0.5836342755697572,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,0.49872331713410634,0.5862046920623322,
HS2024_8_PD_T2,0.49760516291103635,0.6303942339372656,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,0.48567301542125624,,
FR2021_Norm.Intensity.G,0.4895523520672981,0.6006872384851811,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,0.49202957477901493,0.6261380080364158,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,0.5032432713687399,0.6583920911705564,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,0.4911170571000081,,
CR2017_Ratio Replicate 2.3,0.4967735711974883,0.6190034789219306,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,,,
YA2020_Reporter_intensity_Normal_No.2,,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,0.49347729696731396,0.6179941560289394,
HS2024_3_PD_T3,0.5009943740781402,0.6057791533182392,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,0.4914418620206683,0.6042828984529302,
RAM2015_Log2 C,,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,0.5048303556307902,0.6507909401774618,0.25322274392374383
CK2022_2 16-1,0.4758631874894671,0.5943756956365503,
RAM2015_Log2 B,,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,0.49637350064716695,0.6235768218796067,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,0.5049582599714808,0.6023540031040387,
UK2020_HCM_5,0.49494248943388025,0.6193663450784584,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,0.4816497793306548,0.6007683591196051,
PG2020_Intensity Mock_10h_B,,,
WZ2023_Su_025_30min,,,
AH2018_LFQ_4_N,,,
CR2017_Ratio Replicate 1.2,0.5311608960678706,0.6248520132142678,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,0.4901773682302587,0.6407380140737721,
HS2024_8_I_N1,0.482798564065097,0.6147394548959805,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,0.4932411652339331,0.6226277611186048,
AH2018_SILAC_M_1_X,,,
RB2022_7_PreEndurance,0.4852634703894169,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,,0.6131806614996588,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,0.5013262683658589,0.6143147311149297,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,0.49090282261975043,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,,,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,0.4857517787209242,,
KS2014_Intensity C5,,,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,0.4910506320873749,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,0.6281235328866009,
GF2025_P9_Adh,,,
RB2022_3_PostStrength,0.49264889017508856,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,0.4917181702934437,0.6097746181841842,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,
AH2018_LFQ_2_X,,,
PG2020_Intensity 2h_B,,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,0.49602526167312005,,
KS2014_Intensity E15_3,,,
GF2025_P3_Sph,,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.48864830800889253,0.6225623983395944,0.31927566050418243
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,0.4870081818805371,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,0.4735441204889149,0.5771201886872549,
ZQ2022_N1,,,
LY2019_P6-,,0.6121259497098076,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,0.4958802352184654,0.6177761576671899,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,,0.6147653471203913,
AH2018_LFQ_3_N,,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,0.495593356368278,0.6208091948431312,
KBE2022_Log2_Ex_13_U,0.4932211807772442,0.6566539649899606,0.3536238834553747
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,0.6281571250831147,
RB2022_1_RecoverySprint,0.48702799530270036,0.6231151868431367,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,0.47450169937138764,0.6115075871143372,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,0.49739581166608215,,
HS2024_5_PD_T2,0.5061653720829837,0.6154370279164788,
WZ2023_Su_025_20min,,,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,,0.6176711721401723,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,,,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,0.479119257399545,0.6256665052194484,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,0.4890430931677928,0.618554150757821,
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,0.4919309084472633,,
HS2024_3_B_N2,0.5225149065061667,0.6225400207963,
EJN2021_4_Ex_Ins,0.4975495921268366,0.6270824451362551,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,0.49636732212253554,0.6296361173546999,
EP2017_Pervanadate R#3 log2 ratio,,,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,0.4926251927784253,0.6229352395956806,
AH2018_SILAC_MR_3_C,,,
AH2018_LFQ_M_4_C,,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,0.49023763350591015,0.629200810347206,
CK2022_6 40-1,0.4729955070754995,0.610753424775672,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,0.4946248204496654,0.6489306660079347,
LY2019_P3-,,0.6081572791445575,
FR2021_Intensity.A,0.48916368642874897,0.600540766675613,
EJN2021_3_Ex_Ins,0.5038283194276891,0.618554017018726,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,,,
HS2024_8_PD_T3,0.47001317831097233,0.6134082771442833,
EJN2021_3_Ex_Basal,0.4946842450456677,0.625961234822716,
AST2020_Control.1,0.5077708196485519,0.623443277180528,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,,,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,,,
RB2022_1_RecoveryStrength,0.4976258540220436,0.6253467466339522,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,0.4872388585460875,0.5970764604035074,
HS2024_5_B_N1,0.5032873561895049,0.611484446124554,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,,,
RB2022_4_PreSprint,0.49161252886871715,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,,,
HS2024_8_I_N2,0.4801534335522704,0.6075860732671171,
RB2022_3_RecoveryStrength,0.4981309449997747,0.6356922004336495,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,,,
LY2019_P8+,,0.6211799093162603,
RB2022_2_RecoveryEndurance,0.48984691995705204,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,0.48638923284930025,0.6024922142080636,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.49481586412931783,0.6242117335093701,0.2824934585980959
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,0.49328194706660317,0.6472827220895311,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,0.492367252907538,0.6228428446472822,
LY2019_P2-,,0.6124099750005855,
AH2018_LFQ_IT_1_X,,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,0.49993405406776137,0.6522748466601883,
WZ2023_Pe_005_20min,,,
AST2020_Control.2,0.5085954769987022,0.6240025340847521,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,0.5158996327446652,0.625924357205171,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,0.4707789561273972,0.6097933685441763,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,0.4893701273349786,0.6150402249296724,
HS2024_5_B_T2,0.4837959118104359,0.6044952468212639,
HS2024_6_I_T1,0.48257936243987526,0.6190976777420865,
HS2024_5_B_T3,0.5112323867785551,0.632404778514478,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,0.49992942987054606,0.6566919350089186,0.3856813043317289
AH2018_TMTMS3_3_N,,,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,0.4872176550687979,0.5970491057423916,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,,,
KBE2022_Log2_Ex_36_T,0.5054180767688398,0.6591900829725191,0.31491222485511977
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,,,
KS2014_Intensity C2,,,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,0.4941229427547868,0.6459376898523398,
CK2022_9 200-1,0.49960370730413695,0.6448348120285011,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.499835442497473,0.6434188977844864,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,0.4786672649342141,0.6128171819371496,
RBK2021_1332T Late,0.48685973360772244,0.6070265743989318,
LY2019_P1-,,0.6161105485991963,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,0.46749767277241633,0.5853934349749517,
HS2024_3_I_T3,0.4951023861719731,0.6006257973967927,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,,
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,0.4852958172926093,0.6214317043435855,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,0.49240993447752157,0.6452770842530047,
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,,,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,,,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,0.4966624413048713,0.6273912112262757,
KS2014_Intensity N1,,,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.49289950703415264,0.6049213716313097,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,0.4900898067601866,0.6210578592000139,
HS2024_5_B_N2,0.5173277916459941,0.6307852786290532,
HS2024_5_I_N1,0.4993289165861108,0.6179440473297341,
HS2024_6_I_N1,0.48334313562636455,0.5972077236528035,
AR2021_KD 48h,,,
FR2021_Intensity.B,0.4901272221638581,0.6044900529361805,
RB2022_3_PreEndurance,0.4873427077067855,,
HS2024_5_I_T1,0.5056657535585977,0.5978621269633609,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,0.5073827889380578,0.623400962169609,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,,,
KBE2022_Log2_Ex_29_U,0.5071446722687103,0.6587652934308111,0.27196444293846084
HS2024_7_B_T1,0.49420846080656416,0.6189091256992475,
AH2018_LFQ_M_2_X,,,
AH2018_LFQ_IT_4_N,,,
CK2022_15 200-1,0.48408727188135336,0.6357735206967062,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,0.5098675186761825,0.652132731180595,0.2883399489892567
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,,0.6192341185908742,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.4799181773535756,0.6167264458655392,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,,,
RN2012_H01,0.49219761645733423,0.6232962724572372,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,0.49404596481008917,0.620604341420943,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,,,
HS2024_8_B_T3,0.49381663038502627,0.6023203210546526,
YA2020_Reporter_intensity_Cancer_No.3,,,
KBE2022_Log2_Ex_44_U,0.5083245535158739,0.6519915772394363,0.2838200659811658
WZ2023_Pe_010_20min,,,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,0.49201244328210275,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),0.49549424193012975,0.6192868372785496,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,,,
FSO2013_Ratio H/M normalized Rep3___1,,,
AH2018_SILAC_M_3_C,,,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,,
AH2018_SILAC_M_2_X,,,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,0.5050923937097088,0.6557935367605613,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,,,
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,,,
CK2022_15 16-1,0.48253529665774114,0.6150149353985072,
CK2022_3 16-1,0.4754894286647057,0.5943650101434966,
LY2019_P4-,,0.6221746166885066,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,0.5019339221515106,0.6012955184686842,
GF2025_P8_Adh,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,,,
CK2022_10 16-1,0.4966359588751112,0.6255356258173462,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.4920982089792499,0.611956054095671,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,0.494170761504217,0.6192676222158572,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,,,
EJN2021_2_Ex_Basal,0.4905492108566251,0.6246905948171338,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,0.49480717708934613,0.6269112403021598,
AR2021_L41 10 μM,,,
CF2017_EOC 2,0.4918160685015511,0.6186618885343687,
RB2022_6_PostEndurance,0.49399647291524523,,
AH2018_SILAC_1_N,,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,0.4947568909718811,0.6186458442743569,
RB2022_7_PreSprint,0.48671563000168355,0.6174354518037268,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,0.5058981855265148,0.6166345608520745,
CK2022_6 16-1,0.47337118150564184,0.5928573733507017,
ZX2022_CB treated Replicate 1,,,
BS2014_Log2(Ratio H/L normalized Rep_3),0.48946124654481715,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,0.4879852835237421,0.6174945457051731,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,0.4902552696319617,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,,,
AR2021_L41 1 μM,,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,,,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,,,
KS2014_Intensity C4,,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,0.49960209438534103,0.658424768511143,0.24809710711663002
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,0.4955181237820043,0.6167581295487619,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,0.4922848012002829,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,0.4873944255507168,,
AH2018_SILAC_IT_3_C,,,
WZ2023_Pu_025_10min,,,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,,,
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,0.6149679285282827,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,,,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,,
KS2014_Intensity C6,,,
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.48890278834116085,0.6369998177156829,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,0.4774462022745393,0.6260543119115596,
AH2018_SILAC_IT_2_C,,,
CK2022_5 40-1,0.47391119306902935,0.6109571150028943,
AH2018_LFQ_3_X,,,
UK2020_UA_3,0.4965136426325084,0.6194022509607815,
LY2019_P7-,,0.6146578280113785,
GF2025_P5_Adh,,,
RB2022_1_PostStrength,0.49453270234563473,0.6226856622928933,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,,,
SR2019_HCC1954_Biol_repl_3,,,
CR2017_Ratio Replicate 2.2,0.5089947604363153,0.6213879017129426,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,0.6242818227491528,
CK2022_11 16-1,0.4969285896339004,0.6241870134300999,
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,0.520024624593965,0.5928511628641812,
PG2020_Intensity CT_B,,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),0.49141339521726685,0.6199415685335115,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,,
YA2020_Reporter_intensity_Cancer_No.4,,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,,,
RB2022_2_PreEndurance,0.49238231329875415,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,0.5049946794811173,0.6433454333894243,0.28748054148290264
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,0.49088519587350044,0.5990724889052625,
CK2022_14 16-1,0.4834788144543699,0.6135899628539211,
AST2020_anti-CD3+PDL2,0.508054188549223,0.6237091607230586,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,0.4934114633543075,0.6426293189692153,0.36368367368626014
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,0.4909345281564876,,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,0.4684645337236404,0.592027054218499,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),0.4914158395732033,0.6198718250975609,
EP2017_Mitotic R#2 log2 ratio,,,
AH2018_TMTMS2_1_X,,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,0.5070451225279932,0.6312254800837676,
HS2024_6_I_N2,0.4620404866084491,0.5900554829225765,
HH2022_Reporter intensity 4,,0.6147351231855166,
RBK2021_1326T Late,0.48656112622942543,0.6109483114140545,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,0.494353287213031,0.6257246184939071,
HS2024_4_I_T3,0.4860392094254345,0.5950761157629149,
AH2018_SILAC_1_X,,,
PG2020_Intensity 10h_B,,,
AH2018_TMTMS3_1_X,,,
CF2017_FTE 14,0.49028058035903327,0.6182549674011153,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,0.4925725312026524,0.6195276555444654,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,0.4900543524303217,0.6483002981544177,0.3186917151334347
EP2017_Untreated R#2 normalized log2 ratio,,,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,,0.6227452531622251,
HS2024_5_I_N2,0.5056653635569853,0.6324101804707456,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,,,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
